The IPO markets plow ahead with more deals this week and many other filing to start the process. Interestingly enough there are also many companies making board changes, or adjustments which have historically led to a company filing to go public soon after. Many of these names are in the tech space which investors continue to be eager to invest. Even at the sky high valuations they present.

This week we will have four names on the schedule to go public. One is a Chinese education company while the other three are smaller offerings in the biotech space.

The largest of the week is Bright Scholar Education (BEDU  ) which will be seeking $135 million. The company is the largest operator of international and multilingual schools in China. Morgan Stanley will be helping them raise the capital by offering 15 million shares at a range of $8 - $10.

Up next is G1 Therapeutics (GTHX  ) which is a North Carolina based, clinical stage biotech firm. The company is developing therapeutics for cancer and hopes to raise $100 million. To do this they are offering 6.25 million shares at a range of $15 - $17 this week.

The smallest offering of the week comes from Accelerated Pharma (ACCP  ). According to their site they are developing a chemotherapy optimized by genomic screening and are looking to raise only $12 million. They will offer 2.4 million shares at a range of $4 - $6.

Lastly, Netherlands based, Argenx (NASDAQ; ARGX) will be hoping to come to market to raise $65 million. The company, which is developing antibody therapies for rare autoimmune diseases and cancer, will offer 3.6 million shares at a price of $18.18 to hit their goals.